Table 3 Health-related quality of life
From: Cost-effectiveness of fenofibrate for preventing diabetic complications in Australia
Parameter | Value | Source |
|---|---|---|
Total baseline for the cohort | 0.8352 | Bagust et al. 2005 |
Severe Visual Loss | -0.057 | Beaudet et al. 2014 |
Active Ulcer | -0.17 | Beaudet et al. 2014 |
Lower Extremity Amputation Event | -0.28 | Beaudet et al. 2014 |
History of Lower Extremity Amputation | -0.272 | Beaudet et al. 2014 |
End Stage Renal Disease | -0.175 | Beaudet et al. 2014 |
Ischaemic Heart Disease | -0.09 | Beaudet et al. 2014 |
Heart Failure | -0.108 | Beaudet et al. 2014 |
MI event | -0.055 | Beaudet et al. 2014 |
History of subsequent MI | -0.028 | Beaudet et al. 2014 |
First Stroke Event | -0.164 | Beaudet et al. 2014 |
History of First Stroke | -0.115 | Alva et al. 2014 |
Subsequent Stroke Event | -0.164 | Beaudet et al. 2014 |
History of Subsequent Stroke | -0.164 | Alva et al. 2014 |